EU and Mexico Sign Updated Trade Deal to Reduce Dependence on US and China
Leadership Change Casts Shadow Over PayPals Q1 Performance
Setting Up Brokerage Accounts for Grandkids in a Parents Name Potential Pitfalls and Strategic Considerations
Manchester City Faces Strategic Challenge as Bernardo Silva Departure Looms Financial and Squad Implications
EUChina Competitive Gap for Automotive Suppliers Widening Warns CLEPA
Another Airline Files for Bankruptcy and Suspends All Flight Operations
ATMU Q1 2026 Earnings Earnings Per Share Slightly Beats Estimates Amid Positive Market Reaction
Life Time Group Holdings LTH Q1 2026 Earnings EPS Beats Estimates as Membership Trends Strengthen Stock Slips
UAA Q1 2026 Earnings EPS Miss Amid Strategic Restructuring Progress
Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady
Digital Brands Group DBGI Q3 2023 Earnings Heavy Loss Per Share and Sharp Stock Decline Amidst Operational Challenges
FTAIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter
Presidio Property Trust Series D Preferred SQFTP Slips 172 as Preferred Shares Test Key Levels
Hongli Group HLP Faces Resistance Near 050 as Stock Slips by 095
Expand Energy EXE Edges Higher as Natural Gas Markets Show Signs of Stability
Lululemon LULU Edges Higher Amid Consolidation Near Key Resistance Level
Occidental Petroleum OXY Slides 099 as Energy Sector Struggles Key Support Levels Tested
STC Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Title Volume
BHFAO Q1 2026 Earnings Preferred Series B Misses on EPS Despite Modest Stock Uptick
FRAF Q1 2026 Earnings EPS Beats Estimates by 828 Stock Rises
Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress
APYX Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty Shares Slip
SAM Q1 2026 Earnings EPS Misses Estimates Stock Still Gains Ground
SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaway in Market Cap on Debut
BUD Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus
Editas Medicine Surges 1591 Gene Editing Stock Breaks Above Key Support